Comparative Analysis of Ocular Adverse Events between Aflibercept 8 mg and Faricimab: A Global Population-Based Study across 65 Countries.
Saved in:
| Title: | Comparative Analysis of Ocular Adverse Events between Aflibercept 8 mg and Faricimab: A Global Population-Based Study across 65 Countries. |
|---|---|
| Authors: | Lakhani M; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; The University of Ottawa Eye Institute, Ottawa, Ontario, Canada., Popovic MM; Department of Ophthalmology, David Geffen School of Medicine at University of California - Los Angeles (UCLA), Los Angeles, California; Department of Ophthalmology and Visual Sciences, University of Toronto, Toronto, Ontario, Canada., Al-Ani A; Department of Surgery, Section of Ophthalmology, University of Calgary, Alberta, Canada., Kundapur D; The University of Ottawa Eye Institute, Ottawa, Ontario, Canada., Gholamian T; The University of Ottawa Eye Institute, Ottawa, Ontario, Canada., Chaudry E; The University of Ottawa Eye Institute, Ottawa, Ontario, Canada., Nanji K; Department of Surgery, Division of Ophthalmology, McMaster University, Hamilton, Ontario, Canada., Patil N; Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alberta, Canada., Feo A; Department of Ophthalmology, David Geffen School of Medicine at University of California - Los Angeles (UCLA), Los Angeles, California., Sadda S; Department of Ophthalmology, David Geffen School of Medicine at University of California - Los Angeles (UCLA), Los Angeles, California; Doheny Eye Institute, University of California - Los Angeles (UCLA), Pasadena, California., Sarraf D; Department of Ophthalmology, David Geffen School of Medicine at University of California - Los Angeles (UCLA), Los Angeles, California; Stein Eye Institute, University of California - Los Angeles (UCLA), Los Angeles, California., Ip MS; Department of Ophthalmology, David Geffen School of Medicine at University of California - Los Angeles (UCLA), Los Angeles, California., Kertes PJ; Department of Ophthalmology and Visual Sciences, University of Toronto, Toronto, Ontario, Canada; John and Liz Tory Eye Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Muni RH; Department of Ophthalmology and Visual Sciences, University of Toronto, Toronto, Ontario, Canada; Department of Ophthalmology, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Kensington Eye Institute, Kensington Vision and Research Centre, Toronto, Ontario, Canada., Adatia F; Department of Surgery, Section of Ophthalmology, University of Calgary, Alberta, Canada., Damji KF; Department of Surgery, Section of Ophthalmology, University of Calgary, Alberta, Canada; Department of Ophthalmology and Visual Sciences, Aga Khan University, Karachi, Pakistan., Chaudhary V; Department of Surgery, Division of Ophthalmology, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Hurley BR; The University of Ottawa Eye Institute, Ottawa, Ontario, Canada. Electronic address: bhurley@toh.ca. |
| Source: | Ophthalmology. Retina [Ophthalmol Retina] 2026 Apr; Vol. 10 (4), pp. 373-384. Date of Electronic Publication: 2025 Nov 04. |
| Publication Type: | Journal Article; Comparative Study; Multicenter Study |
| Journal Info: | Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
